Serum neopterin concentrations during treatment of leishmaniasis: useful as test of cure?

• Published in: FEMS immunology and medical microbiology Vol. 27; no. 1; pp. 31 - 34
• Main Authors: Hamerlinck, F.F.V., van Gool, T., Faber, W.R., Kager, P.A.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01.01.2000; Blackwell; Oxford University Press
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; AIDS/HIV; Animals; Antimony Sodium Gluconate - therapeutic use; Antiprotozoal Agents - therapeutic use; Biological and medical sciences; Child; Child, Preschool; Cutaneous leishmaniasis; Female; Health care facilities; HIV; HIV Infections - complications; Human immunodeficiency virus; Human protozoal diseases; Humans; Infectious diseases; Interferon; Leishmaniasis; Leishmaniasis, Cutaneous - blood; Leishmaniasis, Cutaneous - drug therapy; Leishmaniasis, Cutaneous - pathology; Leishmaniasis, Visceral - blood; Leishmaniasis, Visceral - complications; Leishmaniasis, Visceral - drug therapy; Leishmaniasis, Visceral - pathology; Leshmaniasis; Macrophages; Male; Medical sciences; Middle Aged; Neopterin; Neopterin - blood; Parasitic diseases; Patients; Pentamidine - therapeutic use; Protozoal diseases; Treatment Outcome; Vector-borne diseases; Visceral leishmaniasis; γ-Interferon; Leishmaniasis; Neopterin; Human; Protozoal disease; Treatment efficiency; Biological marker; Parasitosis; Biological monitoring; Infection; Antiprotozoal agent; Chemotherapy; Treatment; Serum
• ISSN: 0928-8244; 1574-695X; 2049-632X
• DOI: 10.1111/j.1574-695X.2000.tb01408.x

Abstract Neopterin, a product of γ-interferon-activated macrophages, was measured in sera from 28 patients (12 patients with cutaneous leishmaniasis and 16 patients with visceral leishmaniasis) to determine the utility as a marker of disease activity and therapeutic efficacy. Patients originated from Kenya (n=5) and from the Academic Medical Center, Amsterdam, The Netherlands (n=23). In seven patients follow-up sera after treatment were available. Two patients at the time of diagnosis of visceral leishmaniasis were co-infected with HIV. The 12 patients with cutaneous leishmaniasis had serum neopterin levels below the upper limit of the normal range. All 16 patients with visceral leishmaniasis had elevated levels of serum neopterin before treatment. In six out of seven patients with visceral leishmaniasis followed during treatment neopterin levels decreased to values below the upper limit of the normal range (10 nmol l−1). Sequential measurements of serum neopterin levels may be useful for monitoring therapeutic efficacy in patients with visceral leishmaniasis.